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Abstract
Prion diseases or transmissible spongiform encephalopathies (TSEs) are fatal diseases associated with the conver-
sion of the cellular prion protein (PrP
C) to the abnormal prion protein (PrP
Sc). Since the molecular mechanisms in
pathogenesis are widely unclear, we analyzed the global phospho-proteome and detected a differential pattern of
tyrosine- and threonine phosphorylated proteins in PrP
Sc-replicating and pentosan polysulfate (PPS)-rescued N2a
cells in two-dimensional gel electrophoresis. To quantify phosphorylated proteins, we performed a SILAC (stable
isotope labeling by amino acids in cell culture) analysis and identified 105 proteins, which showed a regulated
phosphorylation upon PrP
Sc infection. Among those proteins, we validated the dephosphorylation of stathmin and
Cdc2 and the induced phosphorylation of cofilin in PrP
Sc-infected N2a cells in Western blot analyses. Our analysis
showed for the first time a differentially regulated phospho-proteome in PrP
Sc infection, which could contribute to
the establishment of novel protein markers and to the development of novel therapeutic intervention strategies in
targeting prion-associated disease.
Findings
Transmissible spongiform encephalopathies (TSEs) are
fatal neurodegenerative diseases occurring in many dif-
ferent host species including humans, which develop e.g.
Creutzfeld Jacob disease (sCJD) [1]. The development of
TSEs is associated with the self-propagating conversion
of the normal host cellular prion protein (PrP
C)i n t ot h e
abnormal protease-resistant isoform (PrP
Sc or PrP
res)i n
an autocatalytic manner [2]. PrP
Sc plays a key role as an
infectious agent in certain degenerative diseases of the
central nervous system [3].
The cellular functions of PrP
C and PrP
Sc still remain
enigmatic. The cellular prion protein can be variably gly-
cosylated at two N-glycosylation sites and is C-terminally
attached to the cell surface by a glycosyl phosphatidylino-
sitol (GPI) anchor. GPI-anchored proteins are found in
lipid rafts, highly cholesterol- and glycolipid-enriched
membrane domains associated with a large number of
signaling molecules such as G-protein-coupled receptors
and protein kinases suggesting that signaling transduc-
tion pathways might play a role in TSEs [4]. Hence,
previous publications described a functional role of PrP
C
as a signaling molecule with major findings indicating
that PrP
C interacts with and activates Src family kinases
[5-7]. Increased levels of active Src kinases in scrapie-
infected cells then led to the activation of downstream
signal transduction pathways [8]. Recently, activation of
the JAK-STAT signaling pathway in astrocytes of scra-
pie-infected brains was observed underlining that signal
transduction pathways may play pivotal roles in prion
pathogenesis [9]. Interestingly, it was demonstrated that
inhibition of the non-receptor tyrosine kinase c-Abl
strongly activates the lysosomal degradation of PrP
Sc
[10]. These data indicate that specific interference with
cellular signaling pathways could represent a novel strat-
egy in treatment of TSEs.
We have performed a quantitative analysis of the phos-
pho-proteome to obtain a global insight into deregulated
signal transduction pathways in scrapie-infected neuronal
cells. We analyzed tyrosine- and threonine-phosphorylated
proteins in the murine neuroblastoma cell line N2a58/22L,
which were infected with the PrP
Sc strain 22L [11]. We
have treated N2a58/22L cells with pentosan polysulfate
(PPS), a known inhibitor of 22L PrP
Sc r e p l i c a t i o ni nN 2 a
cells [12], resulting in the PrP
Sc-rescued cell line N2a58#
which served as an uninfected control. Successful rescue
from PrP
Sc was demonstrated in the colony assay as
reflected by the absence of proteinase K (PK)-resistant
PrP
Sc in N2a58# cells after PPS treatment (Figure 1A).
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Sc replication and the effect of PPS-treatment were
further studied in an immunoblot. After PK digestion,
PrP
Sc replication was only observed in N2a58/22L cells
(Figure 1B, lanes 2 and 4). Compared to 22L-infected
N2a58/22L cells, PPS-treated N2a58# cells showed a dif-
ferent glycosylation profile as expected for PrP
C [13-15].
The glycosylation pattern of PrP
C in N2a58# cells dis-
played high amounts of di- and mono-glycosylated PrP
C,
whereas in N2a58/22L cells predominantly mono- and
non-glycosylated PrP
Sc was detected (Figure 1B, lanes 1
and 3). Altogether, PPS treatment of N2a58/22L cells suc-
cessfully abolished PrP
Sc formation in N2a58# cells, which
served as a non-infected control cell line in our study.
To analyze differentially phosphorylated proteins in
N2a58/22L cells in comparison to N2a58# cells, we
separated equal protein amounts by two-dimensional gel
electrophoresis. Gels were stained with Coomassie Blue
to demonstrate equal protein amounts in N2a58/22L
and N2a58# cells (Figure 1C, left panels). In parallel,
gels were blotted onto membranes and incubated
with phospho-specific antibodies to detect tyrosine-
(Figure 1C, middle panels) or threonine-phosphorylated
proteins (Figure 1C, right panels). Interestingly, consid-
erable differences in phosphorylation patterns were
observed (Figure 1C, asterisks), while other phosphory-
lated proteins were not changed in N2a58/22L and
N2a58# cells (Figure 1C). These data imply differentially
regulated phosphoproteins in response to 22L infection
of neuronal cells.
Generally, global detection of phosphorylated proteins
is still challenging, as antisera often recognize phosphory-
lated residues dependent on the surrounding sequence.
For a general detection of proteins post-translationally
phosphorylated at those sites, we performed a SILAC
analysis allowing the identification and relative quantifi-
cation of differential phosphoprotein regulation. There-
fore, N2a58# cells were grown in light isotope containing
and N2a58/22L cells in heavy isotope containing
Figure 1 Differentially phosphorylated proteins in PrP
Sc-positive and -negative N2a cells. (A) PrP
res-positive N2a58/22L cells were treated
with pentosan polysulfate (PPS) to obtain PrP
res-negative N2a58# cells. Successful PPS treatment was validated in a colony assay. Cells were
grown to confluence on cover slips and directly lysed on nitrocellulose. Where indicated 20 μg/ml proteinase K (PK) was added followed by the
detection of PrP expression using the 6H4 monoclonal antibody. In non-treated cells (-), PrP was detected in both, cured and infected N2a cells.
Upon digestion with PK (+), PrP
res was only observed in N2a58/22L cells. (B) Equal amounts of protein lysates were incubated with 20 μg/ml PK
or left untreated. PrP was detected with the 8H4 monoclonal antibody showing the typical migration pattern of PrP and PrP
res in infected and
PPS-treated N2a58# cells. In parallel, lysates were incubated with PK to visualize PK-resistant PrP
res in N2a58/22L. (C) 150 μg of N2a58# or prion-
infected N2a58/22L cell lysates were separated by two-dimensional gel electrophoresis followed either by Coomassie staining or immunoblotting
for detection of tyrosine- and threonine-phosphorylated proteins. Black asterisks indicate changed intensities of protein phosphorylation.
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separated by gel electrophoresis, trypsinized and followed
by enrichment of phosphoproteins, which were then ana-
lyzed by mass spectrometry. We identified 109 different
phosphoproteins of which 105 were also quantified
(Tables 1 and 2). We observed 75 proteins with a ratio of
identified peptides in N2a58/22L versus N2a58#
cells ranging from 0.46 to 0.99 (Table 1). Conversely, 30
phosphoproteins showed a ratio between 1.01 and 1.79
(Table 2). We defined proteins exhibiting a ratio < 0.70
as dephosphorylated proteins and proteins with ratios
between 0.70 and 1.40 as proteins, whose phosphoryla-
tion was not altered in 22L-infected N2a58/22L cells.
Ratios > 1.40 were considered as proteins whose phos-
phorylation increased upon Scrapie infection.
Among quantified phosphoproteins, we then consid-
ered specific phosphosites in selected target proteins,
such as Cdc2, stathmin, and cofilin as analyzed by mass-
spectrometry (Table 3). An increase of cofilin
S3 phos-
phorylation in N2a58/22L cells was suggested by a ratio
1.63, while the amount of the two tyrosine phosphoryla-
tion sites (Y15, Y160) in Cdc2 were decreased upon 22L
infection. Stathmin phosphopeptides containing serine
38 were increased, whereas the amount of stathmin
phosphopeptides harboring serine 25 in N2a58/22L cells
was significantly lower (Table 3).
To validate the results obtained in the SILAC phos-
phoproteomic analysis we performed Western blots for
cofilin 1, Cdc2, and stathmin using antibodies for the
detection of specific phosphosites. As predicted by the
SILAC analysis, cofilin 1 phosphorylation was signifi-
cantly induced in Scrapie-infected N2a58/22L cells com-
pared to PPS-treated N2a58# cells (Figure 2, left panels).
Cofilin represents a potent regulator of the actin fila-
ments, which is controlled by phosphorylation of serine
3 mediated through the LIM-kinase 1 (LIMK-1) in vitro
and in vivo [16]. These data support previous studies
indicating a direct interaction of PrP
Sc with cofilin [17].
Together with our finding that phosphorylation of cofi-
lin is induced in PrP
Sc-infected neuronal cells; the
results indicate a significant role for the protein in neu-
rodegeneration processes. Stathmin acts as an important
regulatory protein of microtubule dynamics, which can
be directly targeted by Cdc2 [18]. In our analysis, we
showed that stathmin
S38 phosphorylation was decreased
( F i g u r e2 ,m i d d l ep a n e l s ) ,w hich correlates with the
inactivation of Cdc2 in N2a58/22L cells (Figure 2, right
panels) implying that there is a functional interaction.
Cdc2 is a crucial kinase in starting M phase events dur-
ing the cell cycle progression and regulates important
mitotic structure changes, including nuclear envelope
breakdown and spindle assembly [19]. Dephosphoryla-
tion of stathmin
S38 led to an inhibition of cells at G2/M
phase, lack of spindle assembly, and growth inhibition
[20,21]. Together with the finding that the prion gene is
transcriptionally activated in the G1 phase in confluent
and terminally differentiated cells [22], we assume that
control of the cell cycle might be important in prion
diseases.
Aberrant signal transduction pathways are implicated
in many diseases. However, perturbations in phosphory-
lation-based signaling networks are typically studied in a
hypothesis-driven approach. In this study, we performed
the first global analysis of the phosphoproteome of scra-
pie-infected neuronal cells, since the knowledge of PrP-
dependent deregulation of the signalling network is
poor. SILAC provides a powerful and accurate technique
for relative proteome-wide quantification by mass-
spectrometry. Its versatility has been demonstrated by a
wide range of applications, especially for intracellular
signal transduction pathways [23-25]. Since we applied
SILAC for the quantitative detection of the phosphopro-
teome in scrapie-infected neuroblastoma cells, we found
105 different phosphoproteins. Among identified pro-
teins, we validated the regulated phosphorylation of cofi-
lin, stathmin and Cdc2 indicating that the identification
of phosphoproteins in scrapie-infected neuronal cells by
SILAC is reliable. Future work is necessary to determine
whether the identified novel phosphoproteins are
involved in prion diseases and if they probably represent
sensitive and specific biomarkers for diagnosis or thera-
peutic intervention strategies.
Methods
Cell culture
N2a58/22L cells have been described previously [11] and
were kindly provided by Prof. Schätzl (LMU, Munich).
Cells were cultured in DMEM containing 10% FCS and
4 mM L-glutamine at 37°C. Cells were treated with
5 μg/ml pentosan polysulfate (Cartrophen Vet, A.
Albrecht GmbH + Co. KG, Germany) for two passages,
resulting in a stable rescued cell line for more than 15
passages (N2a58# cells). Cell lysates were prepared by
scraping cells in lysis buffer containing 150 mM NaCl,
0 . 5 %T r i t o nX - 1 0 0 ,0 . 5 %D O C ,5 0m MT r i sp H7 . 5 ,1
mM Na-vanadate, 1 mM Na-molybdate, 20 mM NaF,
10 mM NaPP, 20 mM β-glycerophosphat, 1× protease
inhibitor cocktail (Roche, Mannheim, Germany). For
digestion with proteinase K (PK) 80 μg protein were
treated with 20 μg/ml PK for 30 min at 37°C. PK diges-
tion was stopped by addition of laemmli sample buffer
and protein denaturation at 95°C for 7 min.
Colony assay
The colony assay was performed as previously described
with minor modifications [26]. In brief, cells were grown
on glass cover slips to confluence using a 24 well plate.
The cell layer was soaked in lysis buffer (150 mM NaCl,
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Page 3 of 9Table 1 Proteins exhibiting decreased phosphorylation in N2a58/22L cells
No. Uniprot Protein Names Ratio
a Pept
b sequence
coverage
[%]
PEP
c Biological
Process
1 P43276 Histone H1.5 0.46237 1 13.9 5.61E-16 nucleosome assembly
2 P30681 High mobility group protein B2 0.48683 2 11 3.33E-02 genome maintenance; differentiation
3 P11440 Cell division control protein 2 homolog 0.49428 5 7.7 3.03E-03 cell cycles; protein phosphorylation
4 P97310 DNA replication licensing factor MCM2 0.54657 1 2.4 1.65E-05 cell cycle; nucleosome assembly;
transcription
5 P43275 Histone H1.1 0.56637 1 19.2 8.42E-04 nucleosome assembly
6 P43274 Histone H1.4 0.58367 4 24.2 1.04E-14 nucleosome assembly
7 Q9Z2X1-1 Heterogeneous nuclear ribonucleoprotein F 0.60054 2 6.5 5.45E-22 RNA processing
8 P70670 Nascent polypeptide-associated complex
subunit alpha, muscle-specific form
0.60501 2 1.2 5.07E-11 protein transport; transcription
9 P60843 Eukaryotic initiation factor 4A-I 0.65781 5 4.9 5.39E-03 translation
10 P27659 60S ribosomal protein L3 0.65906 12 7.7 1.49E-03 translation
11 P28656 Nucleosome assembly protein 1-like 1 0.70087 1 7.2 1.16E-05 nucleosome assembly
12 Q62167 ATP-dependent RNA helicase DDX3X 0.70816 3 3.3 3.12E-19 putative helicase activity
13 P68040 Guanine nucleotide-binding protein subunit
beta-2-like1
0.71371 1 7.9 5.15E-08 unknown
14 P47911 60S ribosomal protein L6 0.71887 7 12 7.26E-07 translation
15 Q61937 Nucleophosmin 0.72062 7 29.8 4.38E-07 cell cycle; nuclear export
16 P15532 Nucleoside diphosphate kinase A 0.72108 2 17.8 7.93E-03 NTP biosynthesis; nervous system
development
17 O70251 Elongation factor 1-beta 0.73137 1 24 2.20E-18 translation
18 Q61656 Probable ATP-dependent RNA helicase DDX5 0.73832 4 3.7 1.41E-03 RNA processing; transcription
19 Q9ERK4 Exportin-2 0.74333 1 2.1 8.97E-05 cell proliferation; protein transport
20 P09411 Phosphoglycerate kinase 1 0.74902 2 6.7 3.40E-03 glycolysis; phosphorylation
21 P48962 ADP/ATP translocase 1 0.75149 6 18.8 3.87E-36 transmembrane transport
22 Q9D8N0 Elongation factor 1-gamma 0.76191 3 7.8 1.45E-10 translation
23 P49312-2 Heterogeneous nuclear ribonucleoprotein A1 0.77303 5 12.1 7.20E-05 alternative splicing; nuclear export/import
24 Q9CZM2 60S ribosomal protein L15 0.77591 9 10.3 2.04E-15 translation
25 P97855 Ras GTPase-activating protein-binding
protein 1
0.78021 2 7.3 1.11E-15 protein transport
26 Q9EQU5-1 Protein SET 0.79357 7 7.9 5.77E-12 nucleosome assembly
27 Q7TPV4 Myb-binding protein 1A 0.79496 2 1.5 2.39E-11 cytoplasmic transport; transcription
28 P80318 T-complex protein 1 subunit gamma 0.79504 1 6.6 2.89E-05 protein folding
29 P25444 40S ribosomal protein S2 0.79516 20 12.3 2.99E-04 translation
30 P10126 Elongation factor 1-alpha 1 0.80203 5 18.6 1.06E-33 translational elongation
31 P61979-2 Heterogeneous nuclear ribonucleoprotein K 0.80502 6 11.9 1.17E-15 RNA processing
32 P07901 Heat shock protein HSP 90-alpha 0.80637 2 32.7 1.38E-94 CD8 T-cell differentiation; chaperone
activity
33 Q61598-1 Rab GDP dissociation inhibitor beta 0.81242 3 5.6 1.93E-05 protein transport; regulation of GTPase
activity
34 P54775 26S protease regulatory subunit 6B 0.81795 2 7.2 1.59E-09 blastocyst development; protein catabolism
35 Q20BD0 Heterogeneous nuclear ribonucleoprotein A/B 0.82349 3 19.3 3.26E-11 nucleotide binding
36 P14206 40S ribosomal protein SA;Laminin receptor 1 0.8261 7 20.7 2.57E-17 translation
37 P68134 Actin, alpha skeletal muscle 0.83457 10 27.3 4.38E-26 cytoskeleton
38 P80314 T-complex protein 1 subunit beta 0.83579 2 11.6 1.05E-21 protein folding
39 P50580 Proliferation-associated protein 2G4 0.84048 2 8.1 1.53E-03 rRNA processing; transcription; translation
40 P11983-1 T-complex protein 1 subunit alpha B 0.84687 4 8.8 5.73E-23 protein folding
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Page 4 of 90.5% Triton X-100, 0.5% DOC, 50 mM Tris pH 7.5) on a
nitrocellulose membrane. After drying for 30 min at
room temperature, the membrane was incubated in lysis
buffer containing 5 μg/ml proteinase K (PK) for 90 min
at 37°C, rinsed twice with water, and incubated in 2 mM
PMSF for 10 min. The membrane was shaken in 3 M
guanidinium thiocyanate, 10 mM Tris-HCl (pH 8.0) for
10 min, followed by rinsing five times with water. 5%
nonfat dry milk in TBS-T was used for blocking for 1 h
at room temperature. PrP was detected using an anti-PrP
Table 1: Proteins exhibiting decreased phosphorylation in N2a58/22L cells (Continued)
41 P35564 Calnexin 0.85134 1 6.3 2.08E-06 protein folding
42 Q8BUP7 Putative uncharacterized protein;26S protease
regulatory subunit 6A
0.85207 3 7.3 9.72E-03 blastocyst development; protein catabolism
43 P63017 Heat shock cognate 71 kDa protein 0.85947 9 32.2 2.16E-96 response to stress
44 Q01768 Nucleoside diphosphate kinase B 0.86107 4 17.8 1.35E-04 NTP biosynthesis
45 P62082 40S ribosomal protein S7 0.86306 3 10.3 8.39E-03 translation
46 P80315 T-complex protein 1 subunit delta 0.86423 1 6.9 3.81E-12 protein folding
47 Q71LX8 Heat shock protein 84b 0.8654 4 32 6.13E-
136
protein folding; stress response
48 P58252 Elongation factor 2 0.86672 2 7.9 3.57E-25 translation
49 P08249 Malate dehydrogenase, mitochondrial 0.86743 1 9.2 2.49E-35 glycolysis
50 P70168 Importin subunit beta-1 0.87257 2 2.7 3.47E-13 nuclear import
51 P51859 Hepatoma-derived growth factor 0.87395 2 12.7 2.95E-07 transcription
52 P14152 Malate dehydrogenase, cytoplasmic 0.87522 1 7.8 1.09E-03 glycolysis
53 P80313 T-complex protein 1 subunit eta 0.89251 1 8.6 1.22E-39 protein folding
54 P62827 GTP-binding nuclear protein Ran 0.89794 3 22.7 2.27E-09 cell cycle; nuclear import; signal
transduction
55 P20029 78 kDa glucose-regulated protein 0.89996 1 7 4.16E-04 cerebellar Purkinje cell development/
organization
56 P56480 ATP synthase subunit beta, mitochondrial 0.90399 1 18.5 1.85E-42 proton transport; lipid metabolism
57 P17742 Peptidyl-prolyl cis-trans isomerase A 0.90719 10 20.4 4.97E-20 neuron differentiation; protein folding
58 P20152 Vimentin 0.90814 10 26.2 2.22E-34 cytoskeleton
59 P09103 Protein disulfide-isomerase 0.91019 2 4.7 8.84E-02 redox homeostasis
60 P80317 T-complex protein 1 subunit zeta 0.91579 1 10.2 1.49E-02 protein folding
61 Q569Z6 Thyroid hormone receptor-associated protein
3
0.93507 3 3.7 4.27E-04 transcription
62 P09405 Nucleolin 0.93545 1 12.7 8.06E-34 nucleotide binding
63 Q9D6F9 Tubulin beta-4 chain 0.93722 4 23.2 9.43E-32 cytoskeleton
64 Q8C2Q7 Heterogeneous nuclear ribonucleoprotein H1 0.93795 3 5.7 2.30E-06 nucleotide binding
65 Q8K019-1 Bcl-2-associated transcription factor 1 0.94132 4 5.3 2.22E-05 transcription
66 P62908 40S ribosomal protein S3 0.94247 2 9.1 1.74E-06 translation
67 P99024 Tubulin beta-5 chain 0.9446 3 36.3 1.15E-54 cytoskeleton
68 P15331-2 Peripherin 0.95087 3 17.2 3.41E-40 cytoskeleton
69 P63038-1 60 kDa heat shock protein, mitochondrial 0.96089 6 13.8 9.17E-37 T cell activation; interferon production
70 P27773 Protein disulfide-isomerase A3 0.96765 1 7.9 1.26E-03 redox homeostasis; apoptosis
71 P16858 Glyceraldehyde-3-phosphate dehydrogenase 0.96943 58 23.4 5.69E-66 glycolysis
72 Q3TED3 Putative uncharacterized protein; ATP-citrate
synthase
0.97174 2 4.3 4.63E-03 acetyl-CoA biosynthesis
73 Q03265 ATP synthase subunit alpha, mitochondrial 0.98925 2 13.6 1.81E-22 proton transport; lipid metabolism
74 Q9ERD7 Tubulin beta-3 chain 0.99071 2 27.3 5.05E-33 cytoskeleton
75 P17751 Triosephosphate isomerase 0.9967 1 11.2 1.52E-04 gluconeogenesis; glycolysis
a. Ratio of N2a58/22L vs. N2a58# cells
b. Number of identified peptides
c. posterior error probability (PEP) estimates the probability of wrong assignment of a spectrum to a peptide sequence
Wagner et al. Cell Communication and Signaling 2010, 8:28
http://www.biosignaling.com/content/8/1/28
Page 5 of 9antibody 6H4 (Prionics) and a HRP-conjugated sheep
anti-mouse antibody (GE Healthcare).
SDS-PAGE and Western Blot
Proteins were separated by 12% SDS-PAGE and trans-
ferred to polyvinylidene difluoride membranes (PVDF,
Millipore) by semidry blotting. PrP was detected using
the PrP-specific mouse mAb 8H4 (Alicon AG). For vali-
dation of phosphorylated proteins anti-phospho-stathmin
(Ser38) (#3426, Cell Signaling Technology), anti-phos-
pho-cdc2 (Tyr15) (#4539, Cell Signaling Technology),
and anti-phospho-cofilin (Ser3) antibodies (#3313, Cell
Signaling Technology) were used. Antibodies recognizing
Table 2 Proteins exhibiting increased phosphorylation in N2a58/22L cells
No. Uniprot Protein Names Ratio
a Pept.
b Sequence
Coverage
[%]
PEP
c Biological
Process
76 P80316 T-complex protein 1 subunit epsilon 1.017 1 6.1 8.63E-18 protein folding
77 Q9CX22 Putative uncharacterized protein;
Cofilin-1
1.0173 5 29.7 3.72E-41 cytoskeleton; protein phosphorylation
78 P32067 Lupus La protein homolog 1.02 2 7.5 1.68E-02 RNA processing
79 A6ZI44 Fructose-bisphosphate aldolase 1.0328 8 12.2 2.75E-25 glycolysis
80 P35700 Peroxiredoxin-1 1.0342 6 6.7 2.44E-10 proliferation; redox homeostasis; stress response
81 P05202 Aspartate aminotransferase,
mitochondrial
1.0344 1 12.3 1.04E-11 aspartate biosynthesis; oxaloacetate metabolism
82 Q3TFD0 Serine hydroxymethyltransferase 1.0425 3 6.5 2.95E-03 carbon metabolism
83 P63101 14-3-3 protein zeta/delta 1.0478 19 19.2 7.09E-27 protein binding
84 Q9CZ30-1 Obg-like ATPase 1 1.0606 3 7.1 2.25E-16 ATP/GTP binding; hydrolase activity
85 P06745 Glucose-6-phosphate isomerase 1.0652 3 7.7 3.34E-15 angiogenesis; gluconeogenesis; glycolysis
86 Q71H74 Collapsin response mediator protein
4A
1.0688 5 6.3 6.94E-12 nervous system development
87 Q6P5F9 Exportin-1 1.0703 2 3.6 2.74E-20 nuclear export; centrosome duplication
88 Q01853 Transitional endoplasmic reticulum
ATPase
1.0708 2 3.7 2.97E-05 apoptosis; retrograde protein transport
89 Q3TCI7 L-lactate dehydrogenase 1.0746 4 18.3 1.43E-32 glycolysis
90 P08113 Endoplasmin 1.08 1 2.6 1.05E-05 protein folding
91 Q8VC46 Ubc protein;Ubiquitin 1.0848 17 30.7 2.18E-06 protein binding
92 A0PJ96 Mtap1b protein 1.0871 2 3.2 2.72E-13 cytoskeleton
93 Q61171 Peroxiredoxin-2 1.0934 2 9.1 4.16E-04 signal transduction; redox homeostasis
94 Q9WVA4 Transgelin-2 1.106 2 11.8 9.37E-05 muscle organ development
95 P52480-1 Pyruvate kinase isozymes M1/M2 1.1081 3 22.2 6.30E-39 glycolysis
96 O08709 Peroxiredoxin-6 1.1204 5 13.8 1.10E-04 redox homeostasis
97 P17182 Alpha-enolase 1.128 11 41.5 6.35E-26 glycolysis
98 P54227 Stathmin 1.1422 4 18.1 1.94E-02 cell cycle; cytoskeleton
99 Q922F4 Tubulin beta-6 chain 1.1427 1 19.2 1.01E-25 cytoskeleton
100 Q60864 Stress-induced-phosphoprotein 1 1.1499 1 3.5 5.12E-05 stress response
101 P52480-2 Pyruvate kinase isozymes M1/M2 1.2958 1 19.6 3.40E-33 glycolysis
102 Q920E5 Farnesyl pyrophosphate synthetase 1.3534 1 8.2 8.44E-16 cholesterol/isoprenoid biosynthesis
103 P38647 Stress-70 protein, mitochondrial 1.357 2 4.6 6.57E-08 nuclear export; protein folding
104 P14824 Annexin A6 1.6252 4 7.9 2.47E-08 Ca
2+ transport; muscle contraction
105 Q61753 D-3-phosphoglycerate dehydrogenase 1.7927 3 8.1 6.28E-15 cell cycle; neural development; serine biosynthesis
a. Ratio of N2a58/22L vs. N2a58# cells
b. Number of identified peptides
c. posterior error probability (PEP) estimates the probability of wrong assignment of a spectrum to a peptide sequence
Table 3 Identified phosphorylation sites
Protein names Ratio
(total)
a
Phosphosite Ratio
(specific phospho-site)
b
Cdc2 0.49428 Y15 0.43086
Y160 0.64359
stathmin 1.1422 S25 1.2155
S38 0.45601
cofilin 1.0173 S3 1.6328
a. Ratio of phosphorylation N2a58/22L vs. N2a58# cells
b. Ratio of phospho sites in N2a58/22L and N2a58# cells
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Page 6 of 9stathmin (#3352), cdc2 (#9112) and cofilin (#3312) were
also obtained from Cell Signaling Technology.
Two dimensional gel electrophoresis
For 2D electrophoresis 150 μg protein of cell lysates were
purified by trichloroacetic acid precipitation and re-sus-
pended in DeStreak Rehydration Solution (Amersham
Biosciences) containing 0.5% Bio-Lyte pH3-10 (Bio-Rad
Laboratories GmbH, München). The isoelectric focusing
was run on IPG strips with a non-linear pH range of 3-10
and a length of 7 cm (Bio-Rad) using the ZOOM®
IPGRunner™system from Invitrogen. After focussing
strips were equilibrated in 50 mM Tris, 1 mM Urea, 30%
Glycerin, 2% SDS, 1% DTT for 25 min and in 50 mM
Tris, 1 mM Urea, 30% Glycerin, 2% SDS, 5% Iodacetamid
for 25 min. Strips were then separated in 10% SDS-PAGE
gels in the second dimension and analyzed by Coomassie
staining or immunoblotting using an anti-phospho-tyro-
sine (sc-7020, Santa Cruz) or an anti-phospho-threonine
antibody (#9381, Cell Signaling Technology).
SILAC phosphoproteomics analysis
SILAC ready-to-use cell culture media and dialyzed FBS
were obtained from Dundee Cell Products Ltd, UK.
While N2a58# cells were cultured in control SILAC
DMEM media containing unlabelled arginine and lysine
amino acids (R0K0), N2a58/22L cells were cultured in
ready-to-use SILAC DMEM medium containing
13C
labeled arginine and lysine amino acids (R6K6) for seven
cell division cycles. After preparation of cell lysates and
measurement of protein concentration, lysates of
N2a58# and N2a58/22L cells were mixed in a ratio 1:1.
Each sample was reduced in SDS PAGE loading buffer
containing 10 mM DTT and alkylated in 50 mM iodoa-
cetamide prior to separation by one-dimensional SDS-
PAGE (4-12% Bis-Tris Novex mini-gel, Invitrogen) and
visualization by colloidal Coomassie staining (Novex,
Invitrogen). The entire protein gel lane was excised and
cut into 10 gel slices each. Every gel slice was subjected
to in-gel digestion with trypsin [27]. The resulting tryp-
tic peptides were extracted by 1% formic acid, acetoni-
trile, lyophilized in a speedvac (Helena Biosciences).
Phosphopeptide enrichment
The lyophilized peptides above were resuspended in 5%
acetic acid (binding buffer) and phosphopeptide enrich-
ment was carried out using immobilized metal ion affi-
nity chromatography (IMAC). Immobilized gallium in
the Pierce Ga-IDA Phosphopeptide Enrichment Kit was
used to enrich for phosphopeptides prior to MS/MS
analysis according to the manufacturer’si n s t r u c t i o n s
(Thermo Scientific).
LC-MS/MS
Trypsin digested peptides were separated using an Ulti-
mate U3000 (Dionex Corporation) nanoflow LC-system
consisting of a solvent degasser, micro and nanoflow
pumps, flow control module, UV detector and a ther-
mostated autosampler. 10 μl of sample (a total of 2 μg)
was loaded with a constant flow of 20 μl/min onto a
P e p M a pC 1 8t r a pc o l u m n( 0 . 3m mi d×5m m ,D i o n e x
Corporation). After trap enrichment peptides were
eluted off onto a PepMap C18 nano column (75 μm×
15 cm, Dionex Corporation) with a linear gradient of
5-35% solvent B (90% acetonitrile with 0.1% formic acid)
over 65 minutes with a constant flow of 300 nl/min.
Figure 2 Specific regulation of cofilin, Cdc2, and stathmin phosphorylation in scrapie-infected neuronal cells. Cell lysates of N2a58# and
22L-infected N2a58/22L cells were analyzed by Western blot using phospho-specific antibodies to detect p-cofilin
S3, p-cdc2
Y15, and p-stathmin
S38
(left panels). As loading controls, equal amounts of cofilin, Cdc2 and stathmin were shown. Quantification of intensities of phosphorylation signal
was performed by normalizing the corresponding loading control (* p < 0.05) (right panels).
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(Thermo Fisher Scientific Inc) via a nano ES ion source
(Proxeon Biosystems). Thes p r a yv o l t a g ew a ss e tt o
1.2 kV and the temperature of the heated capillary was
set to 200°C. Full scan MS survey spectra (m/z 335-
1800) in profile mode were acquired in the Orbitrap
with a resolution of 60,000 after accumulation of
500,000 ions. The five most intense peptide ions from
t h ep r e v i e ws c a ni nt h eO r b i t r a pw e r ef r a g m e n t e db y
collision induced dissociation (normalised collision
energy 35%, activation Q 0.250 and activation time
30 ms) in the LTQ after the accumulation of 10,000
ions. Maximal filling times were 1,000 ms for the full
scans and 150 ms for the MS/MS scans. Precursor ion
charge state screening was enabled and all unassigned
charge states as well as singly charged species were
rejected. The dynamic exclusion list was restricted to a
maximum of 500 entries with a maximum retention
period of 90 seconds and a relative mass window of
10 ppm. The lock mass option was enabled for survey
scans to improve mass accuracy [28]. Data were
acquired using the Xcalibur software.
Quantification and Bioinformatic Analysis
Quantification was performed with MaxQuant version
1.0.7.4 [29], and was based on two-dimensional cen-
troid of the isotope clusters within each SILAC pair.
To minimize the effect of outliers, protein ratios were
calculated as the median of all SILAC pair ratios that
belonged to peptides contained in the protein. The
percentage variability of the quantitation was defined
as the standard deviation of the natural logarithm of
all ratios used for obtaining the protein ratio multi-
plied by a constant factor 100.
The generation of peak list, SILAC- and extracted ion
current-based quantitation, calculated posterior error
probability, and false discovery rate based on search
engine results, peptide to protein group assembly, and
data filtration and presentation was carried out using
MaxQuant. The derived peak list was searched with the
Mascot search engine (version 2.1.04; Matrix Science,
London, UK) against a concatenated database combining
80,412 proteins from International Protein Index (IPI)
human protein database version 3.6 (forward database),
and the reversed sequences of all proteins (reverse data-
base). Alternatively, database searches were done using
Mascot (Matrix Science) as the database search engine
and the results saved as a peptide summary before quan-
tification using MSQuant http://msquant.sourceforge.
net/. Parameters allowed included up to three missed
cleavages and three labeled amino acids (arginine and
lysine). Initial mass deviation of precursor ion and frag-
ment ions were up to 7 ppm and 0.5 Da, respectively.
The minimum required peptide length was set to 6
amino acids. To pass statistical evaluation, posterior
error probability (PEP) for peptide identification (MS/MS
spectra) should be below or equal to 0.1. The required
false positive rate (FPR) was set to 5% at the peptide
level. False positive rates or PEP for peptides were calcu-
lated by recording the Mascot score and peptide
sequence length-dependent histograms of forward and
reverse hits separately and then using Bayes’ theorem in
deriving the probability of a false identification for a
given top scoring peptide. At the protein level, the false
discovery rate (FDR) was calculated as the product of the
PEP of a protein’s peptides where only peptides with dis-
tinct sequences were taken into account. If a group of
identified peptide sequences belong to multiple proteins
and these proteins cannot be distinguished, with no
unique peptide reported, these proteins are reported as a
protein group in MaxQuant. Proteins were quantified if
at least one MaxQuant-quantifiable SILAC pair was pre-
sent. Identification was set to a false discovery rate of 1%
with a minimum of two quantifiable peptides. The set
value for FPR/PEP at the peptide level ensures that the
worst identified peptide has a probability of 0.05 of being
false; and proteins are sorted by the product of the false
positive rates of their peptides where only peptides with
distinct sequences are recognized. During the search,
proteins are successively included starting with the best-
identified ones until a false discovery rate of 1% is
reached; an estimation based on the fraction of reverse
protein hits.
Enzyme specificity was set to trypsin allowing for clea-
vage of N-terminal to proline and between aspartic acid
and proline. Carbamidomethylation of cysteine was
searched as a fixed modification, whereas N-acetyl pro-
tein, oxidation of methionine and phosphorylation of
serine, threonine and tyrosine were searched as variable
modifications.
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